(Q45880914)

17 December 2017

title

Effect of therapeutic immunization using Ad5/35 and MVA vectors on SIV infection of rhesus monkeys undergoing antiretroviral therapy (English)

1 reference

17 December 2017

main subject

anti-retroviral agent

0 references

0 references

0 references

M Shimada

1

1 reference

17 December 2017

H-B Wang

2

1 reference

17 December 2017

A Kondo

3

1 reference

17 December 2017

X-P Xu

4

1 reference

17 December 2017

A Yoshida

5

1 reference

17 December 2017

K Shinoda

6

1 reference

17 December 2017

T Ura

7

1 reference

17 December 2017

H Mizuguchi

8

1 reference

17 December 2017

D Klinman

9

1 reference

17 December 2017

J-L Luo

10

1 reference

17 December 2017

H Bai

11

1 reference

17 December 2017

K Okuda

12

1 reference

17 December 2017

publication date

16 October 2008

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

16

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

218-228

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/gt.2008.152

exact match

0 references

cites work

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Immune control of HIV-1 after early treatment of acute infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Control of HIV despite the Discontinuation of Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Prevalence and predictive value of intermittent viremia with combination hiv therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Vaccination of macaques with long-standing SIVmac251 infection lowers the viral set point after cessation of antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Viremia control following antiretroviral treatment and therapeutic immunizationduring primary SIV251 infection of macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Therapeutic dendritic-cell vaccine for simian AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV-infected rhesus monkeys undergoing antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Heterologous human immunodeficiency virus type 1 priming-boosting immunization strategies involving replication-defective adenovirus and poxvirus vaccine vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Characterization of subsets of CD4+ memory T cells reveals early branched pathways of T cell differentiation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

HIV pathogenesis: the first cut is the deepest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Pathogenesis of macrophage tropic HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Mamu-B*08-positive macaques control simian immunodeficiency virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Control of simian immunodeficiency virus SIVmac239 is not predicted by inheritance of Mamu-B*17-containing haplotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.152

Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption

21 January 2018

1 reference

12 December 2020

Early immune activation in gut-associated and peripheral lymphoid tissue during acute HIV infection

1 reference

12 December 2020

T cell dynamics in HIV-1 infection

1 reference

12 December 2020

DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued

1 reference

12 December 2020

The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl)

1 reference

12 December 2020

Identifiers

DOI

10.1038/GT.2008.152

1 reference

17 December 2017

Dimensions Publication ID

1049340630

0 references

1 reference

17 December 2017